Molecure S.A.
MOC.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | PLN 204 | PLN 328 | PLN 200 | PLN 522 |
| - Cash | PLN 18 | PLN 64 | PLN 66 | PLN 102 |
| + Debt | PLN 7 | PLN 7 | PLN 6 | PLN 6 |
| Enterprise Value | PLN 193 | PLN 271 | PLN 141 | PLN 426 |
| Revenue | PLN 3 | PLN 0 | PLN 8 | PLN 0 |
| % Growth | 2,919,000% | -100% | 1,878,262.3% | – |
| Gross Profit | -PLN 0 | -PLN 4 | -PLN 0 | -PLN 3 |
| % Margin | -16.8% | -4,101,610% | -0.3% | -693,272.5% |
| EBITDA | -PLN 27 | -PLN 26 | -PLN 32 | -PLN 13 |
| % Margin | -937.8% | -25,505,806% | -423.9% | -3,332,504.8% |
| Net Income | -PLN 31 | -PLN 28 | -PLN 14 | -PLN 14 |
| % Margin | -1,071.8% | -28,373,117% | -180.2% | -3,410,639% |
| EPS Diluted | -1.55 | -1.69 | -2.56 | -0.98 |
| % Growth | 8.3% | 34% | -161.2% | – |
| Operating Cash Flow | -PLN 57 | -PLN 23 | -PLN 10 | -PLN 13 |
| Capital Expenditures | -PLN 24 | -PLN 0 | -PLN 34 | -PLN 19 |
| Free Cash Flow | -PLN 81 | -PLN 24 | -PLN 44 | -PLN 32 |